Biotechnology
Technology
Health

United Therapeutics

$74.85
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.47 (-0.62%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell UTHR and other stocks, options, ETFs, and crypto commission-free!

About UTHR

United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. Read More The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

Employees
860
Headquarters
Silver Spring, Maryland
Founded
1996
Market Cap
3.30B
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
521.26K
High Today
$75.66
Low Today
$74.65
Open Price
$75.50
Volume
330.67K
52 Week High
$130.00
52 Week Low
$74.65

Collections

Biotechnology
Technology
Health
Pharmaceutical
Therapy
Research And Development
Silver
Metals

UTHR News

Barron'sJul 1

United Therapeutics Stock Jumps After Analyst Says Its Slide Was Overdone

139
CNBCJun 27

This CEO is trying to genetically modify pig organs for human transplant and turn more Sci-Fi ideas into common cures

122

UTHR Earnings

$2.55
$3.15
$3.76
$4.36
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Jul 31, Pre-Market

More UTHR News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.